Topiramate in migraine prophylaxis: Long-term impact on resource utilization and cost

Headache

Volumn 47, Issue 4, 2007, Pages 500-510

  Silberstein, Stephen D ^a   Feliu, Anthony L ^b   Rupnow, Marcia F T ^c   Blount, Angela C ^b   Boccuzzi, Stephen J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b PharMetrics Inc   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Cost; Headache; Migraine; Prevention; Resource use; Topiramate

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; ERGOTAMINE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOTHIAZINE; PROPRANOLOL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TIMOLOL; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST UTILITY ANALYSIS; DIAGNOSTIC PROCEDURE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; COST OF ILLNESS; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; PHARMACEUTICAL SERVICES; RETROSPECTIVE STUDIES;

EID: 34247242675     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2007.00754.x     Document Type: Article

References (15)

1. Collins JG. Prevalence of selected chronic conditions, United States, 1979-1981. Vital Health Statistics. 1986;10:1-66.
2. American Migraine Study II: NHF Information; National Headache Foundation. Available at: http://www.headaches.org/consumer/presskit/AMS.2/NHF. htm. Accessed June 12, 2006.
3. Migraine Update; National Institute of Neurological Disorders and Stroke. Available at: http://www.ninds.nih.gov/disorders/migraine/migraine.htm. Accessed June 12, 2006.
4. Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines formigraine headache in the primary care setting: Pharmacologic management for prevention of migraine. 2000. Available at: http://www.aan.com/professionals/practice/pdfs/gl0090.pdf. Accessed June 12, 2006.
5. Snow V, Weiss K, Wall EM, Mottur-Pilsun C. American Academy of Family Physicians; American College of Physicians - American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840-849.
6. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: A randomized controlled trial. JAMA. 2004;291:965-973.
7. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group. Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol. 2004;61:490-495.
8. Diener HC, Tfelt-Hansen P, Dahlöh C, et al. Topiramate in migraine prophylaxis: Results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251:943-950.
9. Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin. 2006;22:1021-1029.
10. Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC. Topiramate improves health-related quality of life when used to prevent migraine. Headache. 2005;45:1023-1030.
11. Vermilyea JA, Feliu AL, Rupnow MFT, Carter C, Blount A, Ollendorf DA. Topiramate in the prophylaxis of migraine: Impact on resource utilization [poster]. Academy of Managed Care Pharmacy's 2005 Educational Conference; October 5-8, 2005, Nashville, TN.
12. Romano PS, Roos LL, Jollis JG. Adapting a Clinical Comorbidity Index for Use with ICD-9-CM Administrative Data: Differing Perspectives. J Clin Epidemiol. 1993;46:1075-1079, Discussion 81-90.
13. Package Insert - TOPAMAX® (topiramate) Tablets and TOPAMAX® (topiramate capsules) Sprinkle Capsules. Ortho-McNeil Neurologics, Inc. Titusville, NJ 08560. Revised June 2005.
14. Lofland JH, Rupnow MFT, Gagne JJ, Smith D, Poston S, Pizzi LT, Papadopoulos G. Impact of topiramate for migraine prophylaxis on workplace productivity: Results from a large U.S., randomized, doubleblind, placebo-controlled, multicenter trial. Neurology. 2006;66(5 suppl 2):A223.
15. Pizzi L, Gagne JJ, Lofland JH, Rupnow M, Poston S. Effect of topiramate migraine prophylaxis on work-place productivity: results from two U.S. randomized, double-blind, placebo-controlled, multicenter trials. Headache. 2006;46:852.